OmniaBio is a Canadian contract development and manufacturing organization (CDMO) specializing in cell and gene therapies. Based in Hamilton, Ontario, OmniaBio operates GMP facilities for clinical and commercial-scale manufacturing. The company differentiates itself with a focus on advanced therapies and strategic partnerships to bring regenerative medicines to market. Canadian operations support clients in biomanufacturing process development and regulatory compliance.